Due to legal requirements (see, amongst others, Article 13 of Implementing Regulation (EU) No. 520/2012), marketing authorization holders of medicinal products must conduct risk-based audits of their quality systems.
The planning, execution and follow-up of such audits are extremely time-consuming. In addition, these audits must be carried out by personnel who, on the one hand, has the appropriate qualifications but, on the other hand, has no direct involvement in or responsibility for the issues or processes to be audited.
Therefore, the commissioning of an external auditor is a resource-saving opportunity for many companies. Phavigus supports you in this area with the following services:
Phavigus - Dr. Uwe Schulz | Pharmacovigilance Consulting & Auditing | Hauptstraße 10 ¼ | 86482 Aystetten | Germany
© Copyright 2023 Dr. Uwe Schulz. All rights reserved.